Information for Doctors

Are you a DOCTOR looking for more details about our practice?

Thoracic Medicine

Think you might have a breathing disorder or just looking for more information?

Sleep Medicine

Latest News

A recent study has shown that adaptive servoventilation (ASV) may be harmful in heart failure patients with central sleep apnoea. The results indicated a 10% annual risk of cardiovascular death in ASV patients compared with 7.5% in the control group. The overall survival and hospitalisation rate was not different between the groups.

Read more...
 

Researchers find that having sleep apnea while pregnant could make the baby prone to metabolic disease as an adult. The study suggests that reoccurring oxygen deprivation, during pregnancy causes long-term changes in the offspring's liver's ability to maintain blood glucose level.

Read more...
 

Symptoms of depression and insomnia are the strongest predictors of having frequent nightmares, a new study concludes. A nightmare disorder may occur when repeated nightmares cause distress or impairment in social or occupational functioning.

Read more...
 

Navigational brain cells that help sense direction are as electrically active during deep sleep as they are during wake time, scientists have discovered. Such information could be useful in treating navigational problems associated with Alzheimer's disease and other neurological disorders.

Read more...
 

A team of neuropsychologists at Saarland University have shown that even a brief sleep of 45 to 60 minutes can significantly improve retention of learned material in memory

Read more...
 

People exposed to prolonged periods of shortened sleep have significant increases in blood pressure during nighttime hours, researchers report.

Read more...

Link between obstructive sleep apnea and increased bone resorption in men

A recent Japanese study is first evidence of a link between obstructive sleep apnoea (OSA) and abnormal bone metabolism, due to the effects of hypoxia, microinflammation and oxidative stress.

osabones1

Obstructive sleep apnea (OSA) is a prevalent disorder and should be considered a systemic illness.

Studies have shown that the pro-inflammatory cytokines interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFalpha) are elevated in patients with OSA independently of obesity and that visceral fat.

OSA in obese patients is now considered manifestations of the Metabolic Syndrome, include:

  • obesity without OSA is associated with daytime sleepiness;
  • PCOS and diabetes type 2 are independently associated with EDS after controlling for SDB, obesity, and age;
  • increased prevalence of OSA in post-menopausal women, with hormonal replacement therapy associated with a significantly reduced risk for OSA;
  • lack of effect of continuous positive airway pressure (CPAP) in obese patients with apnea on hypercytokinemia and insulin resistance indices; and
  • the prevalence of the metabolic syndrome in the US population from the Third National Health and Nutrition Examination Survey (1988-1994) parallels the prevalence of symptomatic OSA in general random samples. Finally, the beneficial effect of a cytokine antagonist on EDS in obese, male apneics and that of exercise on SDB in a general random sample, supports the hypothesis that cytokines and insulin resistance are mediators of EDS and sleep apnea in humans.

 Hypoxia, micro-inflammation and oxidative stress are also known to affect bone metabolism.

osabones2

Model for mediation of effects of E on osteoclast formation and function by cytokines in bone marrow microenvironment.

The bone metabolic abnormalities in patients with OSA were studied, specifically the serum/ urinary levels of bone resorption markers and their attenuation following CPAP therapy in subjects with OSA.

The study was a cross-sectional and prospective study and was conducted in 50 consecutive male subjects visiting a sleep clinic and 15 age-matched control subjects without OSA. Plasma concentrations of IL-1β, IL-6, TNF-alfa, 3-nitrotyrosine, osteocalcin, bone-specific alkaline phosphatase (BAP), and urinary concentrations of cross-linked C-terminal telopeptide of type I collagen (CTX) were examined before and after 3 months' CPAP in subjects with OSA.

 The results showed that the plasma levels of the cytokines as well as the urinary CTX levels were higher in subjects with severe OSA than in those with mild OSA or control subjects. Significant decrease of the urinary excretion of CTX (before: 211±107 vs. after: 128±59 μg/mmol/creatinine; p<0.01) as well as of the plasma levels of the cytokines was observed following 3 months' CPAP.

Overall this study found that increased OSA severity correlates with the serum/ urinary levels of bone resorption markers and there is reversal following CPAP in subjects with OSA.

More information on Bone Metabolism

© copyright 2010 | All Rights Reserved | Web Design Brisbane by iFactory